LCP
ANIP icon

Lombardia Capital Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Lombardia Capital Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,722
Closed -$258K – 221
2015
Q4 		$258K Sell
5,722
-7,398
-56% -$318K 0.01% 190
2015
Q3 		$518K Buy
13,120
+1,527
+13% +$86.9K 0.02% 164
2015
Q2 		$719K Buy
+11,593
New +$690K 0.02% 167

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

Lombardia Capital Partners's ANIP Position: Q1 2016 in Review

Lombardia Capital Partners sold out of ANI Pharmaceuticals (ANIP) in Q1 2016, closing a stake of 5,722 shares — an estimated $258K sold.

Lombardia Capital Partners first reported a position in ANIP in Q2 2015 and held it in 3 quarters. The position peaked at $719K in Q2 2015. 121 funds tracked by Wall St. Rank hold ANIP as of Q1 2016.

  • Lombardia Capital Partners reported no remaining ANI Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Lombardia Capital Partners sold 5,722 ANI Pharmaceuticals shares in Q1 2016, an estimated $258K.
  • Lombardia Capital Partners first reported a position in ANI Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Lombardia Capital Partners's ANI Pharmaceuticals position peaked at $719K in Q2 2015.
  • 121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2016.

Based on Lombardia Capital Partners's 13F filing for Q1 2016, filed 13 May 2016.